Insider Trading Activity Dermira, Inc. (NASDAQ:DERM) – Director Bought 30,000 shares of Stock

ME Staff

7 years ago

Insider Trading Activity For Dermira, Inc. (NASDAQ:DERM)

Fred B Craves , Director of Dermira, Inc. (NASDAQ:DERM) reportedly Bought 30,000 shares of the company’s stock at an average price of 23.03 for a total transaction amount of $690,900.00 SEC Form

Insider Trading History For Dermira, Inc. (NASDAQ:DERM)

On 10/8/2014 Bay City Capital Llc, Director, bought 69,112 with an average share price of $16.00 per share and the total transaction amounting to $1,105,792.00.View SEC Filing

On 11/25/2014 Matthew K Fust, Director, bought 6,000 with an average share price of $16.77 per share and the total transaction amounting to $100,620.00.View SEC Filing

On 9/14/2015 Eugene A Bauer, Insider, sold 22,500 with an average share price of $28.05 per share and the total transaction amounting to $631,125.00.View SEC Filing

On 10/1/2015 Eugene A Bauer, Insider, sold 2,500 with an average share price of $22.87 per share and the total transaction amounting to $57,175.00.View SEC Filing

On 11/2/2015 Eugene A Bauer, Insider, sold 2,500 with an average share price of $27.82 per share and the total transaction amounting to $69,550.00.View SEC Filing

On 12/1/2015 Eugene A Bauer, Insider, sold 2,500 with an average share price of $29.65 per share and the total transaction amounting to $74,125.00.View SEC Filing

On 1/4/2016 Thomas G Wiggans, CEO, sold 11,000 with an average share price of $33.17 per share and the total transaction amounting to $364,870.00.View SEC Filing

Analyst Ratings For Dermira, Inc. (NASDAQ:DERM)
These are 3 Sell Ratings, 6 Buy Ratings .
The current consensus rating for Dermira, Inc. (NASDAQ:DERM) is Hold (Score: 2.33) with a consensus target price of $43.80 , a potential (83.26% upside)

Analyst Ratings History For Dermira, Inc. (NASDAQ:DERM)

On 8/19/2015 Cowen and Company Initiated Coverage of rating Outperform with a price target of $40.00
On 6/2/2016 Wedbush Boost Price Target of rating Outperform with a price target of $42.00 to $46.00
On 10/5/2016 Leerink Swann Reiterated Rating Buy
On 1/3/2017 SEB Equity Research Reiterated Rating Reduce
On 3/2/2017 Guggenheim Reiterated Rating Buy to Positive with a price target of $40.00
On 3/15/2017 Citigroup Inc. Initiated Coverage of rating Underperform
On 3/16/2017 Raymond James Financial, Inc. Initiated Coverage of rating Underperform to Underperform

Recent Trading Activity for Dermira, Inc. (NASDAQ:DERM)
Shares of Dermira, Inc. closed the previous trading session at 23.90 up +0.65 2.80% with 490,968 shares trading hands.